Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) shares traded up 3.3% on Monday . The company traded as high as $3.80 and last traded at $3.74. Approximately 45,694 shares traded hands during mid-day trading, a decline of 18% from the average daily volume of 55,882 shares. The stock had previously closed at $3.62.
Wall Street Analyst Weigh In
A number of research firms recently issued reports on CDLX. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Thursday, June 18th. Wall Street Zen lowered shares of Cardlytics from a “hold” rating to a “sell” rating in a research report on Saturday, June 13th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Cardlytics in a research note on Wednesday, July 8th. Finally, Lake Street Capital set a $10.00 price target on shares of Cardlytics in a report on Friday, May 8th. Two research analysts have rated the stock with a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, Cardlytics has an average rating of “Reduce” and a consensus price target of $10.00.
Read Our Latest Stock Analysis on CDLX
Cardlytics Stock Down 0.5%
Insider Buying and Selling
In other Cardlytics news, CFO David Thomas Evans bought 15,000 shares of the business’s stock in a transaction that occurred on Friday, May 15th. The shares were acquired at an average cost of $6.50 per share, for a total transaction of $97,500.00. Following the transaction, the chief financial officer directly owned 26,793 shares in the company, valued at approximately $174,154.50. This represents a 127.19% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Amit Gupta sold 9,640 shares of the business’s stock in a transaction that occurred on Monday, July 6th. The stock was sold at an average price of $4.39, for a total transaction of $42,319.60. Following the sale, the chief executive officer directly owned 113,850 shares in the company, valued at $499,801.50. The trade was a 7.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 18,289 shares of company stock valued at $80,289. 5.90% of the stock is owned by company insiders.
Institutional Trading of Cardlytics
Several institutional investors have recently modified their holdings of the business. XTX Topco Ltd raised its position in Cardlytics by 143.5% during the 2nd quarter. XTX Topco Ltd now owns 85,971 shares of the company’s stock worth $141,000 after purchasing an additional 50,663 shares during the last quarter. Marshall Wace LLP acquired a new position in Cardlytics during the 2nd quarter worth about $59,000. Jane Street Group LLC grew its position in shares of Cardlytics by 263.0% in the 2nd quarter. Jane Street Group LLC now owns 162,427 shares of the company’s stock valued at $267,000 after buying an additional 117,687 shares during the last quarter. Private Advisor Group LLC bought a new stake in shares of Cardlytics in the 3rd quarter valued at about $272,000. Finally, UBS Group AG increased its stake in shares of Cardlytics by 112.5% in the third quarter. UBS Group AG now owns 458,066 shares of the company’s stock valued at $1,113,000 after buying an additional 242,536 shares during the period. Institutional investors own 68.10% of the company’s stock.
About Cardlytics
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Recommended Stories
- Five stocks we like better than Cardlytics
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
